Investigating antibodies that target oxidized phospholipids to improve bone health in older adults

Antibodies against Oxidized Phospholipids and Osteoporosis

NIH-funded research Central Arkansas Veterans Hlthcare Sys · NIH-11009539

This study is looking at how a special antibody might help prevent bone loss as we age, which could be really helpful for older adults dealing with osteoporosis.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCentral Arkansas Veterans Hlthcare Sys NIH-funded
Lab location1 site (North Little Rock, United States)
Project IDNIH-11009539 on NIH RePORTER

What this research studies

This research focuses on understanding how antibodies against oxidized phospholipids (OxPLs) can help prevent bone loss associated with aging and osteoporosis. The study uses transgenic mice that produce a specific antibody, E06-scFv, which has shown promise in increasing bone mass and promoting bone formation. By analyzing the effects of these antibodies on bone cells and their genetic activity, the research aims to uncover new therapeutic strategies for enhancing bone health in older individuals.

Who could benefit from this research

Good fit: Ideal candidates for this research are older adults at risk for osteoporosis or those experiencing age-related bone loss.

Not a fit: Patients who are younger and do not have any risk factors for osteoporosis may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or reverse bone loss in older adults, reducing the risk of osteoporosis-related fractures.

How similar studies have performed: Previous research has shown that targeting oxidized phospholipids can have beneficial effects in other conditions, suggesting potential success for this novel approach in osteoporosis.

Where this research is happening

North Little Rock, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions age associated diseaseage associated disorderage dependent diseaseage dependent disorderage related human disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.